Interleukins: Role in cancer and its immunotherapy
Institute of Science, Nirma University, Ahmedabad, Gujarat 382481, India.
Review
World Journal of Biology Pharmacy and Health Sciences, 2024, 20(01), 082–092.
Article DOI: 10.30574/wjbphs.2024.20.1.0701
Publication history:
Received on 19 August 2024; revised on 26 September 2024; accepted on 28 September 2024
Abstract:
Interleukins are a very important family of cytokines; they are the messengers that assist immune cells to communicate with each other. Interleukins plays a pivotal role in innate and adaptive immune responses by balancing immune cell proliferation, differentiation and regulation. Interleukins aid immune cells in killing cancer cells while simultaneously assisting cancer cells in evading the immune response which leads tumor formation. Some interleukins are very effective at activating effector immune cells to kill cancer cells and also used for cancer immunotherapy. Interleukins are utilized in cancer immunotherapy alone or in combination with other therapies such as CAR-T, checkpoint inhibitors, or chemotherapy. In this review, we will explore the role of different interleukins in cancer and how researchers modified and therapeutically used them to treat cancer (e.g. IL-2, IL-12, IL-15, IL-17, IL-6, IL-18 etc.,).
Keywords:
Interleukins, Cancer Immunotherapy; Immune Response; Immune Surveillance; Immune Suppression; Tumor Microenvironment
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0